222 related articles for article (PubMed ID: 22182842)
1. Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes.
Rees MG; Ng D; Ruppert S; Turner C; Beer NL; Swift AJ; Morken MA; Below JE; Blech I; ; Mullikin JC; McCarthy MI; Biesecker LG; Gloyn AL; Collins FS
J Clin Invest; 2012 Jan; 122(1):205-17. PubMed ID: 22182842
[TBL] [Abstract][Full Text] [Related]
2. Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.
Rees MG; Wincovitch S; Schultz J; Waterstradt R; Beer NL; Baltrusch S; Collins FS; Gloyn AL
Diabetologia; 2012 Jan; 55(1):114-22. PubMed ID: 22038520
[TBL] [Abstract][Full Text] [Related]
3. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.
Beer NL; Tribble ND; McCulloch LJ; Roos C; Johnson PR; Orho-Melander M; Gloyn AL
Hum Mol Genet; 2009 Nov; 18(21):4081-8. PubMed ID: 19643913
[TBL] [Abstract][Full Text] [Related]
4. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.
Orho-Melander M; Melander O; Guiducci C; Perez-Martinez P; Corella D; Roos C; Tewhey R; Rieder MJ; Hall J; Abecasis G; Tai ES; Welch C; Arnett DK; Lyssenko V; Lindholm E; Saxena R; de Bakker PI; Burtt N; Voight BF; Hirschhorn JN; Tucker KL; Hedner T; Tuomi T; Isomaa B; Eriksson KF; Taskinen MR; Wahlstrand B; Hughes TE; Parnell LD; Lai CQ; Berglund G; Peltonen L; Vartiainen E; Jousilahti P; Havulinna AS; Salomaa V; Nilsson P; Groop L; Altshuler D; Ordovas JM; Kathiresan S
Diabetes; 2008 Nov; 57(11):3112-21. PubMed ID: 18678614
[TBL] [Abstract][Full Text] [Related]
5. Inheritance of rare functional GCKR variants and their contribution to triglyceride levels in families.
Rees MG; Raimondo A; Wang J; Ban MR; Davis MI; Barrett A; Ranft J; Jagdhuhn D; Waterstradt R; Baltrusch S; Simeonov A; Collins FS; Hegele RA; Gloyn AL
Hum Mol Genet; 2014 Oct; 23(20):5570-8. PubMed ID: 24879641
[TBL] [Abstract][Full Text] [Related]
6. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.
Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC
Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768
[TBL] [Abstract][Full Text] [Related]
7. The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326.
Ford BE; Chachra SS; Rodgers K; Moonira T; Al-Oanzi ZH; Anstee QM; Reeves HL; Schattenberg JM; Fairclough RJ; Smith DM; Tiniakos D; Agius L
Mol Metab; 2023 Jun; 72():101722. PubMed ID: 37031802
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
9. Glucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism.
Raimondo A; Rees MG; Gloyn AL
Curr Opin Lipidol; 2015 Apr; 26(2):88-95. PubMed ID: 25692341
[TBL] [Abstract][Full Text] [Related]
10. Current Insight on the Role of Glucokinase and Glucokinase Regulatory Protein in Diabetes.
Paliwal A; Paliwal V; Jain S; Paliwal S; Sharma S
Mini Rev Med Chem; 2024; 24(7):674-688. PubMed ID: 37612862
[TBL] [Abstract][Full Text] [Related]
11. Evolution of hepatic glucose metabolism: liver-specific glucokinase deficiency explained by parallel loss of the gene for glucokinase regulatory protein (GCKR).
Wang ZY; Jin L; Tan H; Irwin DM
PLoS One; 2013; 8(4):e60896. PubMed ID: 23573289
[TBL] [Abstract][Full Text] [Related]
12. An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of
Cheung CYY; Tang CS; Xu A; Lee CH; Au KW; Xu L; Fong CHY; Kwok KHM; Chow WS; Woo YC; Yuen MMA; Cherny SS; Hai J; Cheung BMY; Tan KCB; Lam TH; Tse HF; Sham PC; Lam KSL
Diabetes; 2017 Jun; 66(6):1723-1728. PubMed ID: 28385800
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic Effects of Common and Rare
Yeh KH; Hsu LA; Teng MS; Wu S; Chou HH; Ko YL
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328045
[TBL] [Abstract][Full Text] [Related]
14. Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD.
Belalcazar LM; Papandonatos GD; Erar B; Peter I; Alkofide H; Balasubramanyam A; Brautbar A; Kahn SE; Knowler WC; Ballantyne CM; McCaffery JM; Huggins GS;
Circ Cardiovasc Genet; 2016 Feb; 9(1):71-8. PubMed ID: 26578543
[TBL] [Abstract][Full Text] [Related]
15. Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes.
Tracz A; Madzio J; Gnys P; Malachowska B; Borowiec M; Wyka K; Jarosz-Chobot P; Mysliwiec M; Szadkowska A; Mlynarski W; Fendler W;
Exp Clin Endocrinol Diabetes; 2014 Oct; 122(9):503-9. PubMed ID: 24918535
[TBL] [Abstract][Full Text] [Related]
16. ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits.
Singh C; Jin B; Shrestha N; Markhard AL; Panda A; Calvo SE; Deik A; Pan X; Zuckerman AL; Ben Saad A; Corey KE; Sjoquist J; Osganian S; AminiTabrizi R; Rhee EP; Shah H; Goldberger O; Mullen AC; Cracan V; Clish CB; Mootha VK; Goodman RP
Cell Metab; 2024 Jan; 36(1):144-158.e7. PubMed ID: 38101397
[TBL] [Abstract][Full Text] [Related]
17. Relevant associations of the glucokinase regulatory protein/glucokinase gene variation with TAG concentrations in a high-cardiovascular risk population: modulation by the Mediterranean diet.
Sotos-Prieto M; Guillén M; Vicente Sorli J; Portolés O; Guillem-Saiz P; Ignacio Gonzalez J; Qi L; Corella D
Br J Nutr; 2013 Jan; 109(2):193-201. PubMed ID: 22716779
[TBL] [Abstract][Full Text] [Related]
18. Type 1 Hyperlipoproteinemia Due to Compound Heterozygous Rare Variants in GCKR.
Shetty S; Xing C; Garg A
J Clin Endocrinol Metab; 2016 Nov; 101(11):3884-3887. PubMed ID: 27403930
[TBL] [Abstract][Full Text] [Related]
19. Kinetic Basis of Carbohydrate-Mediated Inhibition of Human Glucokinase by the Glucokinase Regulatory Protein.
Casey AK; Miller BG
Biochemistry; 2016 May; 55(21):2899-902. PubMed ID: 27174229
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism.
Pollin TI; Jablonski KA; McAteer JB; Saxena R; Kathiresan S; Kahn SE; Goldberg RB; Altshuler D; Florez JC;
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1142-7. PubMed ID: 21525158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
